...
首页> 外文期刊>Kidney international. >Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions
【24h】

Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions

机译:连续性非卧床腹膜透析和血液透析:比较合并症后的患者死亡率

获取原文
           

摘要

Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. A historical prospective national sample of 1,725 diabetic and 2,411 non-diabetic Medicare end-stage renal disease (ESRD) patients incident from 1986 to 1987 was analyzed for the mortality of patients selected to receive continuous ambulatory peritoneal dialysis (CAPD) or hemodialysis (HD) with adjustment for patient characteristics, including the presence of comorbid conditions at onset of ESRD. Cox proportional hazards analyses were used to compare the mortality of CAPD and HD patients. Patients were followed from 30 days following onset of ESRD until two to four years post-onset. No statistically significant difference in relative mortality risk (RR) was found among non-diabetic patients selected for CAPD compared to HD (RR = 0.84 for CAPD versus HD, P = 0.25), while evidence of higher adjusted mortality for CAPD compared to HD was found among diabetic patients (RR = 1.26, P = 0.03). Mortality analyses adjusted for pre-treatment risk factors suggest that CAPD and HD provide incident non-diabetic ESRD patients with similar expected survival outcomes. Evidence that increased mortality was associated with CAPD among diabetic patients, particularly among elderly patients, suggests the need for further controlled studies of mortality among CAPD patients with diabetes.
机译:持续性非卧床腹膜透析和血液透析:比较合并症后患者的死亡率。分析了从1986年至1987年发生的1,725例糖尿病和2,411例非糖尿病Medicare终末期肾脏疾病(ESRD)患者的历史前瞻性国家样本,分析了接受连续非卧床腹膜透析(CAPD)或血液透析(HD)的患者的死亡率调整患者特征,包括在ESRD发作时出现合并症。使用Cox比例风险分析来比较CAPD和HD患者的死亡率。患者从ESRD发作后30天开始随访,直至发病后2至4年。与HD相比,选择CAPD的非糖尿病患者的相对死亡风险(RR)在统计学上没有显着差异(CAPD vs HD,RR = 0.84,P = 0.25),而与HD相比,CAPD调整后死亡率更高的证据是在糖尿病患者中发现(RR = 1.26,P = 0.03)。根据治疗前危险因素进行的死亡率分析表明,CAPD和HD可为非糖尿病ESRD患者提供相似的预期生存结果。糖尿病患者,特别是老年患者中,死亡率增加与CAPD有关的证据表明,需要对糖尿病CAPD患者中的死亡率进行进一步的对照研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号